Fig. 4From: Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional studyChanges in dose or dosage regimen at Visit 2 (n = 772/774) – Efficacy populationBack to article page